Takeda, CSL to end alliance as plasma-based COVID-19 drug fails key test,

The medicine was developed by Takeda and CSL through an alliance that included several other drug manufacturers and a clinical trial network set …, The medicine was developed by Takeda and CSL through an alliance that included several other drug manufacturers and a clinical trial network set …, Read More

Scroll to Top